1,090
Participants
Start Date
December 31, 2015
Primary Completion Date
March 31, 2018
Study Completion Date
March 31, 2018
ESAT6-CFP10 (10ug/ml) in left arm and TB-PPD in right arm
All subjects including TB subjects and non-TB subjects with lung disease inject ESAT6-CFP10 (10ug/ml) in left arm and TB-PPD in right arm respectively. Two drug must use at the same participant and in different arms.
ESAT6-CFP10 (10ug/ml) in right arm and TB-PPD in left arm
All subjects including TB subjects and non-TB subjects with lung disease inject ESAT6-CFP10 (10ug/ml) in right arm and TB-PPD in left arm respectively. Two drug must use at the same participant and in different arms.
Wuxi NO.5 People's Hospital, Wuxi
Shanghai Public Health clinical Center, Shanghai
Shanghai Public Health Clinical Center
OTHER_GOV
Tianjin Haihe Hospital
OTHER
Air Force Military Medical University, China
OTHER
Proswell Medical Corporation
INDUSTRY
Wuhan Institute for Tuberculosis Control
OTHER
Beijing Chest Hospital
OTHER
Wuxi Hospital for Infectious Diseases
OTHER
First Affiliated Hospital of Chongqing Medical University
OTHER
Fuzhou Pulmonary Hospital of Fujian
OTHER
Zhenjiang Third People's Hospital
UNKNOWN
Anhui Provincial Hospital
OTHER_GOV
Shenzhen Third People's Hospital
OTHER
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
INDUSTRY